Surrogate endpoints in global health research: still searching for killer apps and silver bullets?

por Pai, Madhukar, Schumacher, Samuel G, Abimbola, Seye
Publicado 2018

Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study

por Kendall, Emily A., Schumacher, Samuel G., Denkinger, Claudia M., Dowdy, David W.
Publicado 2017

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifam...

por Howlett, Patrick, Nabeta, Pamela, Tukvadze, Nestan, Schumacher, Samuel G., Denkinger, Claudia M.
Publicado 2021

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis

por Ricks, Saskia, Denkinger, Claudia M., Schumacher, Samuel G., Hallett, Timothy B., Arinaminpathy, Nimalan
Publicado 2020

Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study

por Muyoyeta, Monde, Kerkhoff, Andrew D., Chilukutu, Lophina, Moreau, Emmanuel, Schumacher, Samuel G., Ruhwald, Morten
Publicado 2021

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection

por Georghiou, Sophia B., Alagna, Riccardo, Cirillo, Daniela M., Carmona, Sergio, Ruhwald, Morten, Schumacher, Samuel G.
Publicado 2021

Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis

por Ricks, Saskia, Kendall, Emily A., Dowdy, David W., Sacks, Jilian A., Schumacher, Samuel G., Arinaminpathy, Nimalan
Publicado 2021

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis

por Nathavitharana, Ruvandhi R., Cudahy, Patrick G.T, Schumacher, Samuel G., Steingart, Karen R., Pai, Madhukar, Denkinger, Claudia M.
Publicado 2017

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

por Kohli, Mikashmi, Schiller, Ian, Dendukuri, Nandini, Dheda, Keertan, Denkinger, Claudia M, Schumacher, Samuel G, Steingart, Karen R
Publicado 2018

Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies

por Schumacher, Samuel G., Sohn, Hojoon, Qin, Zhi Zhen, Gore, Genevieve, Davis, J. Lucian, Denkinger, Claudia M., Pai, Madhukar
Publicado 2016

What if They Don’t Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis

por Houben, Rein M G J, Lalli, Marek, Kranzer, Katharina, Menzies, Nick A, Schumacher, Samuel G, Dowdy, David W
Publicado 2019

Advances in Molecular Diagnosis of Tuberculosis

por MacLean, Emily, Kohli, Mikashmi, Weber, Stefan F., Suresh, Anita, Schumacher, Samuel G., Denkinger, Claudia M., Pai, Madhukar
Publicado 2020

Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis

por Samuels, Thomas H. A., Wyss, Romain, Ongarello, Stefano, Moore, David A. J., Schumacher, Samuel G., Denkinger, Claudia M.
Publicado 2021

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

por Kohli, Mikashmi, Schiller, Ian, Dendukuri, Nandini, Yao, Mandy, Dheda, Keertan, Denkinger, Claudia M, Schumacher, Samuel G, Steingart, Karen R
Publicado 2021

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis

por Haraka, Frederick, Kakolwa, Mwaka, Schumacher, Samuel G, Nathavitharana, Ruvandhi R, Denkinger, Claudia M, Gagneux, Sebastien, Reither, Klaus, Ross, Amanda
Publicado 2021

317. Use cases for rapid antigen-detecting tests for COVID-19 screening and surveillance: a systematic review

por Anand, Apoorva, Bigio, Jacob, MacLean, Emily, Underwood, Talya, Pai, Nitika Pant, Carmona, Sergio, Schumacher, Samuel G, Toporowski, Amy
Publicado 2022

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study

por Havumaki, Joshua, Hillemann, Doris, Ismail, Nazir, Omar, Shaheed Vally, Georghiou, Sophia B., Schumacher, Samuel G., Boehme, Catharina, Denkinger, Claudia M.
Publicado 2017

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

por Pillay, Samantha, Steingart, Karen R, Davies, Geraint R, Chaplin, Marty, De Vos, Margaretha, Schumacher, Samuel G, Warren, Rob, Theron, Grant
Publicado 2022

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis

por Solans, Belén P, Béranger, Agathe, Radtke, Kendra, Mohamed, Ali, Mirzayev, Fuad, Gegia, Medea, Linh, Nguyen Nhat, Schumacher, Samuel G, Nahid, Payam, Savic, Radojka M
Publicado 2023

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

por Horne, David J, Kohli, Mikashmi, Zifodya, Jerry S, Schiller, Ian, Dendukuri, Nandini, Tollefson, Deanna, Schumacher, Samuel G, Ochodo, Eleanor A, Pai, Madhukar, Steingart, Karen R
Publicado 2019